Chairman of the House Oversight Committee Rep. Elijah Cummings (D-MD) launched an investigation today into the drug pricing practices of 12 pharmaceutical companies.
A number of companies named in the investigation saw their stock prices fall, including Amgen (NSDQ:AMGN), AbbVie (NYSE:ABBV), AstraZeneca (NYSE:AZN), Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). A hearing is reportedly set for Jan. 29 and will include patients affected by rising drug costs.
Get the full story at our sister site, Drug Delivery Business News.
The post Pharma stocks fall as Rep. Cummings launches drug pricing investigation appeared first on MassDevice.
from MassDevice http://bit.ly/2RLYk00
Cap comentari:
Publica un comentari a l'entrada